Shares of Humana Inc. (NYSE:HUM) hit a new 52-week high during trading on Wednesday . The company traded as high as $253.27 and last traded at $252.99, with a volume of 581,987 shares changing hands. The stock had previously closed at $250.22.

A number of analysts have recently commented on the company. Cowen and Company restated an “outperform” rating and issued a $230.00 price target on shares of Humana in a report on Tuesday, April 25th. Leerink Swann boosted their price target on Humana from $250.00 to $265.00 and gave the company an “outperform” rating in a report on Tuesday, May 30th. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $257.00 price target on the stock in a report on Thursday, May 25th. BidaskClub lowered Humana from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. Finally, UBS AG restated a “neutral” rating and issued a $237.00 price target (up from $205.00) on shares of Humana in a report on Wednesday, June 28th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $243.00.

The firm has a 50-day moving average price of $237.33 and a 200 day moving average price of $221.21. The firm has a market cap of $36.67 billion, a PE ratio of 20.875 and a beta of 0.91.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The company had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same quarter last year, the business posted $2.30 EPS. On average, analysts forecast that Humana Inc. will post $11.45 EPS for the current year.

In other news, SVP Brian P. Leclaire sold 4,971 shares of the firm’s stock in a transaction that occurred on Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the completion of the sale, the senior vice president now owns 14,258 shares in the company, valued at approximately $3,421,920. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Heidi S. Margulis sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, May 26th. The stock was sold at an average price of $231.96, for a total transaction of $347,940.00. Following the sale, the vice president now owns 8,150 shares of the company’s stock, valued at approximately $1,890,474. The disclosure for this sale can be found here. Company insiders own 0.80% of the company’s stock.

Large investors have recently modified their holdings of the company. Guardian Life Insurance Co. of America raised its stake in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares during the last quarter. Independent Portfolio Consultants Inc. raised its position in Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares in the last quarter. Point72 Asia Hong Kong Ltd acquired a new position in Humana during the first quarter worth $128,000. Westbourne Investment Advisors Inc. acquired a new position in Humana during the second quarter worth $205,000. Finally, Hengehold Capital Management LLC acquired a new position in Humana during the second quarter worth $209,000. Institutional investors own 99.66% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/09/humana-inc-hum-reaches-new-1-year-high-at-253-27.html.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.